semaglutide patent Brazilian federal court denies extension Generic injectable semaglutide could cost

If you try ALCAR, start slow and pay attention to the way you feel

In a statement to Insider, Novo Nordisk, the company that makes Wegovy and Ozempic, said that Gila monsters and the discovery of exendin-4 "did not have anything to do with our decision to develop long-acting GLP-1 receptor agonists" for obesity, because "that was based on GLP-1 biology in humans." But the company also said that "the GLP-1-like effect of exendin-4" in Gila monsters was "an important contribution to the field," as it led to the development of the very first injectable drug of its kind

More research is needed, especially to explore direct cardioprotective effects of GLP-1

J Steroid Biochem 1987;27(4-6):11351144